ARCHIVES

Senate Emphasizes Balance In NCI’s Research Programs

This article is from The Cancer Letter archive.

Vol. 19 No. 37 | September 24, 1993

Download PDF Visit The Full Archive

Related Articles

NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial

May 14, 2010

How Elite Institutions Were Affected By A Decade of Constricted Funding

October 31, 2014

Cancer Policy; Board Suggests More Detailed Items In Tobacco Agreement

August 22, 1997

Fox Chase-Penn Program Wins Comprehensive Designation; OMB Tries To Limit Number to 21

October 11, 1974

DCT Board Approves Three New BRMP RFAs For Immunologic Research, $1.5 Million A Year

February 27, 1987

Novel Agents Promise Relief From Hematologic Side Effects

July 27, 2001